Skip to main content
OpenTrials

Clinical trial condition

Pemphigoid, Bullous

Explore clinical trials studying Pemphigoid, Bullous. Study availability and eligibility vary by location and protocol.

38 public trials 2 recruiting studies
Refine in advanced search Browse all conditions

Pemphigoid, Bullous trial results

Recruiting

Phase 1b Trial of RAY121 in Immunological Diseases (RAINBOW Trial)

NCT06371417

Conditions
Antiphospholipid Syndrome, Antiphospholipid Syndrome (APS), Autoimmune Diseases, +50 more
Locations
  • University of California-Irvine Orange, California, United States
  • Johns Hopkins University Baltimore, Maryland, United States
  • Northwell Health, LLC PRIME Lake Success, New York, United States
  • Hospital for Special Surgery New York, United States
View all 77 locations
View Trial Details
Recruiting

Autoimmune Blistering Diseases Study

NCT02753777

Conditions
Autoimmune Diseases, Bullous Pemphigoid, Immune System Diseases, +7 more
Locations
  • Hospital of the University of Pennsylvania, Department of Dermatology Philadelphia, Pennsylvania, United States
  • Hospital of the University of Pennsylvania Philadelphia, Pennsylvania, United States
  • University of Pennsylvania, Department of Dermatology Philadelphia, Pennsylvania, United States
View Trial Details
Enrolling by Invitation

Phase 1b Long-term Extension Trial of RAY121 in Immunological Diseases (RAINBOW-LTE Trial)

NCT06723106

Conditions
Antiphospholipid Syndrome, Antiphospholipid Syndrome (APS), Autoimmune Diseases, +50 more
Locations
  • Royal Prince Alfred Hospital Camperdown, New South Wales, Australia
  • Westmead Hospital Sydney, New South Wales, Australia
  • Campbelltown Public Hospital Sydney, New South Wales, Australia
  • The Alfred Hospital Melbourne, Victoria, Australia
View all 62 locations
View Trial Details
Completed

A Study to Evaluate the Efficacy and Safety of Dupilumab in Adult Patients With Bullous Pemphigoid

NCT04206553

Conditions
Autoimmune Diseases, Bullous Pemphigoid, Immune System Diseases, +4 more
Locations
  • Regeneron study Site Birmingham, Alabama, United States
  • Regeneron Study Site Scottsdale, Arizona, United States
  • Regeneron Study Site Redwood City, California, United States
  • Regeneron Study Site Farmington, Connecticut, United States
View all 53 locations
View Trial Details

Related conditions